Project 101081786

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

101081786 Generated on: Nov 10, 2023

Key Action: Partnerships for cooperation and exchanges of practices


Action Type: Erasmus Mundus Joint Master

Project Title

EMMaH - Euro-Asian Joint Master Programme in


Medical Technology and Healthcare Business

Project Coordinator

Organisation UNIVERSITE DE LILLE

Address 59000 , FR

Website https://www.univ-lille.fr/

Project Information

Identifier 101081786

Start Date Nov 1, 2022

End Date Dec 31, 2028

EC Contribution 3,666,000 EUR

Partners INSTITUTO POLITECNICO DO PORTO (PT) , HOCHSCHULE FUR


ANGEWANDTE WISSENSCHAFTEN HAMBURG (DE) , TAIPEI
MEDICAL UNIVERSITY FOUNDATION*TMU (TW)

The content of this page is published for information purposes only. The project was funded by the European Union. However, the communication about the project
that is published through this page expresses the views of the project beneficiaries only and it does not represent the views of the European Union or the European
Commission. It shall not be deemed to constitute legal or official notice on behalf of the European Union or the European Commission. Neither the European Union
nor the European Commission can be held responsible for this content nor the use thereof made by any third parties. Page 1 of 2
101081786 Generated on: Nov 10, 2023

Project Summary

The Euro-Asian Joint Master programme in Medical Technology and Healthcare Business (EMMaH) is a 2-year
(120 ECTS) course, taught in English and run by the University of Lille (France), Hamburg University of Applied
Sciences (Germany), the Polytechnic Institute of Porto (Portugal), and Taipei Medical University (Taiwan).
Supported by a multicultural and multidisciplinary team of 46 staff, EMMaH covers different fields, from
biomedical technologies and clinical research to healthcare business. The fast-changing healthcare diagnostics
sector, boosted by innovation and demographic evolutions, is confronted with transformation in the healthcare
landscapes. EMMaH’s main outcome is to reduce the lack of human resources in the research and
technology-based sector of health science and biomedical engineering by increasing employability over a wide
spectrum of positions and responsibilities. In four editions designed for 85 students, the consortium would
allocate 60 EMJM high-level scholarships to excellent students worldwide to study one semester on each EU
campus and complete a master thesis with any of the 4 partners. Graduates are awarded a joint diploma
co-signed by the EU partners, the MSc from TMU and digital graduation certificates. EMMaH includes 13
associated partners (companies: Air Liquide, apoQlar, Bayer, IQVIA, Siemens; research institutes: INSERM,
NHRI, ITRI; networks: RACS, CONIF; and HEIs: IFSF Brazil, HES-SO and UExeter), which contribute to
strengthen the employability and supervise student projects and master theses. Moreover, they co-organize job
fairs and offer industry and hospital internships. EMMaH partners carry out the EMJM project through two work
packages: Project management and coordination; Student selection and supervision; Curriculum implementation;
Promotion; Impact, sustainability and dissemination of results. Each partner leads tasks and coordinates activities
in its field of expertise, all co-create and co-develop a set of 25 outputs.

Link to project card: Show project card

The content of this page is published for information purposes only. The project was funded by the European Union. However, the communication about the project
that is published through this page expresses the views of the project beneficiaries only and it does not represent the views of the European Union or the European
Commission. It shall not be deemed to constitute legal or official notice on behalf of the European Union or the European Commission. Neither the European Union
nor the European Commission can be held responsible for this content nor the use thereof made by any third parties. Page 2 of 2

You might also like